drugset / Trial / NCT02195154
18F-DTBZ PET and Multi-modal MRI in the Patients With Vascular Parkinsonism
Phase 2
Completed
13 enrolled
Chang Gung Memorial Hospital
National Science and Technology Council, Taiwan · collab
NaSingle-groupOpen-labelDiagnostic
Summary
Forty patients with clinically diagnosed VP and 20 healthy subjects will be enrolled in the study. Each evaluable subject involved in this study must fulfill all the inclusion and exclusion criteria and each subject will have 3 visits in the study, as one screening visit, one imaging visit, and one safety evaluation visit.
Timeline
- Start
- 2013-11
- Primary completion
- 2017-07-31
- Completion
- 2017-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-DTBZ | Diagnostic / imaging agent | 370 mbq | Intravenous |